Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment
The rapid evolution of influenza virus makes antiviral drugs less effective, which is considered to be a major bottleneck in antiviral therapy. The key proteins in the host cells, which are related with the replication cycle of influenza virus, are regarded as potential drug targets due to their dis...
Main Authors: | Mian Zu, Chao Li, Jian-Song Fang, Wen-Wen Lian, Ai-Lin Liu, Li-Shu Zheng, Guan-Hua Du |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/20/11/19653 |
Similar Items
-
5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency
by: Ahmed K. ElHady, et al.
Published: (2021-02-01) -
Inhibition of a Novel CLK1-THRAP3-PPARγ Axis Improves Insulin Sensitivity
by: Zhenguo Wang, et al.
Published: (2021-08-01) -
Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability
by: Kenichi Iwai, et al.
Published: (2018-06-01) -
RNA-Binding Proteins CLK1 and POP7 as Biomarkers for Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma
by: Xiuping Yang, et al.
Published: (2021-09-01) -
Influenza challenging the diagnosis and management of pulmonary coccidioidomycosis
by: Luis David Chora-Hernández, et al.
Published: (2020-09-01)